Implementation of a Lung Cancer Screening Program in Two Federally Qualified Health Centers.
Lesley WatsonMegan M CotterShauna ShaferKara NelomsRobert A SmithKatherine SharpePublished in: Public health reports (Washington, D.C. : 1974) (2021)
Using low-dose computed tomography (LDCT) to screen for lung cancer is associated with improved outcomes among eligible current and former smokers (ie, aged 55-77, at least 30-pack-year smoking history, current smoker or former smoker who quit within the past 15 years). However, the overall uptake of LDCT is low, especially in health care settings with limited personnel and financial resources. To increase access to lung cancer screening services, the American Cancer Society partnered with 2 federally qualified health centers (FQHCs) in Tennessee and West Virginia to conduct a pilot project focused on developing and refining the LDCT screening referral processes and practices. Each FQHC was required to partner with an American College of Radiology-designated lung cancer screening center in its area to ensure high-quality patient care. The pilot project was conducted in 2 phases: 6 months of capacity building (January-June 2016) followed by 2 years of implementation (July 2016-June 2018). One site created a sustainable LDCT referral program, and the other site encountered numerous barriers and failed to overcome them. This case study highlights implementation barriers and factors associated with success and improved outcomes in LDCT screening.
Keyphrases
- healthcare
- quality improvement
- primary care
- low dose
- computed tomography
- public health
- smoking cessation
- artificial intelligence
- magnetic resonance imaging
- squamous cell carcinoma
- metabolic syndrome
- study protocol
- health information
- type diabetes
- randomized controlled trial
- social media
- risk assessment
- human health
- deep learning
- machine learning
- double blind
- lymph node metastasis
- young adults
- squamous cell